Basics 89bio, Inc. Common Stock IPO Date: November 19, 2021 Sector: Healthcare Industry: Biotech Market Cap: $2.2B Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 3.35% Avg Daily Range (30 D): $0.05 | 0.52% Avg Daily Range (90 D): $0.15 | 1.58% Institutional Daily Volume Avg Daily Volume: .98M Avg Daily Volume (30 D): 6.74M Avg Daily Volume (90 D): 3.11M Trade Size Avg Trade Size (Sh.): 108 Avg Trade Size (Sh.) (30 D): 352 Avg Trade Size (Sh.) (90 D): 186 Institutional Trades Total Inst.Trades: 1,672 Avg Inst. Trade: $2.36M Avg Inst. Trade (30 D): $3.23M Avg Inst. Trade (90 D): $3.06M Avg Inst. Trade Volume: .2M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.54M Avg Closing Trade (30 D): $4.94M Avg Closing Trade (90 D): $3.04M Avg Closing Volume: 224.08K     News Oct 16, 2025 @ 8:58 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith Sep 27, 2025 @ 4:09 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Sep 26, 2025 @ 9:30 PM $HAREHOLDER ALERT: The M&A Class Action Firm Is In... Source: Juan Monteverde Sep 23, 2025 @ 10:30 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Sep 20, 2025 @ 12:49 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.71 $-.49 $-1.39 Diluted EPS $-.71 $-.49 $-1.39 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -111.5M $ -71.28M $ -149.07M Operating Income / Loss $ -115.82M $ -75.91M $ -151.94M Cost of Revenue $ $ $ Net Cash Flow $ -186.32M $ 189.34M $ -120.81M PE Ratio